JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwasaki, T.
Right arrow Articles by Nagai, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwasaki, T.
Right arrow Articles by Nagai, R.
Journal of Nuclear Medicine Vol. 42 No. 1 130-137
© 2001 by Society of Nuclear Medicine


BASIC SCIENCE INVESTIGATIONS

Immunoscintigraphy of Aortic Dissection with 99mTc-Labeled Murine Anti–Smooth Muscle Myosin Monoclonal Antibody in Rats

Toshiya Iwasaki, Tsutomu Iwasaki, Yasushi Aihara, Tsugiyasu Kanda, Noboru Oriuchi, Keigo Endo, Hirohisa Katoh, Toru Suzuki and Ryozo Nagai

Second Department of Internal Medicine and Department of Nuclear Medicine, Gunma University School of Medicine, Gunma; Immunology Laboratory, Diagnostic Division, Yamasa Corporation, Chiba; and Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan

Aortic dissection is among the most common of fatal conditions of the aorta. Prompt and accurate diagnosis of the site and extent of the lesion is necessary for adequate therapy. However, this catastrophic disease, characterized by extensive damage to smooth muscle cells, lacks specific signs and symptoms. As a result, the diagnosis is still frequently missed today and a new diagnostic method to specifically identify aortic dissection would be attractive. The purpose of this study was to examine the feasibility of radioimmunoscintigraphy using 99mTc-anti–smooth muscle myosin monoclonal antibody (SM-MAb) for the noninvasive diagnosis of aortic dissection in the rat experimental model. Methods: The accumulation of 99mTc-anti-SM-MAb was studied, and scintigraphic imaging with 99mTc-anti-SM-MAb was performed in rats immediately after experimental aortic dissection and 1 and 2 wk later. Results: The radioactivity of 99mTc-anti-SM-MAb in the dissected aorta showed a significant increase compared both with the normal portion of the aorta and with blood 6 h after injection of the radiotracer; the ratio of the percentage injected dose per gram (%ID/g) in the lesion to that retained in the normal portion was 4.17 ± 1.47. Scintigraphic imaging with 99mTc-anti-SM-MAb allowed distinct visualization of the dissected aorta with specific accumulation of antibody 6 h after tracer injection. Selective accumulation of the tracer in the dissected portion of the aorta persisted even 1 wk after aortic injury, allowing clear visualization of the dissected lesion by scintigraphy. Conclusion: Radioimmunoscintigraphy using anti-SM-MAb is a potentially useful noninvasive diagnostic method for imaging aortic dissection.

Key Words: radioimmunoscintigraphy • myosin • smooth muscle • dissecting aortic aneurysm







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.